# Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

> **NCT06665737** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 126 (estimated)

## Conditions studied

- Non-Hodgkin's Lymphoma (NHL)
- Granulocyte Colony Stimulating Factor
- Febrile Neutropenia (FN)
- Myelosuppression Adult

## Interventions

- **DRUG:** Early receiving G-CSF group
- **DRUG:** Late receiving G-CSF group

## Key facts

- **NCT ID:** NCT06665737
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-02-27
- **Final completion:** 2026-12-31
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665737, "Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06665737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*